Insiders · Profile

RiverVest Venture Fund IV, L.P.

10% owner at Xilio Therapeutics. Filing since 26 Oct 2021. CIK 0001725443

Company

Date

Role

Action

Shares

Amount

Of holding

XLO Xilio Therapeutics, Inc.

26 Oct 2021

10% owner

Bought

250,000

$4.00M

21.0%

1 decision on file.